- Q1 2024 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$25.04 (-3.36%)Earnings
- Q4 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2024$28.89 (-2.43%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Mirum Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$28.39 (-0.11%)Earnings
- Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Mirum Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023$24.88 (-0.16%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Q1 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$27.85 (-2.59%)Earnings
- Q4 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 08, 2023$23.76 (-0.13%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$20.02 (-16.37%)Earnings
- Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call TranscriptOct 24, 2022
- Q2 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$26.05 (+11.80%)Earnings
- Q1 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$25.03 (+6.15%)Earnings
- Q4 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2022$22.8 (+7.55%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$15.49 (-2.46%)Earnings
- Mirum Pharmaceuticals Inc To Discuss FDA Approves LIVMARLI Call TranscriptSep 29, 2021
- Q2 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$14.54 (-0.62%)Earnings
- Q1 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$17.7 (-6.50%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Mirum Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 09, 2020
Mirum Pharmaceuticals Inc at UBS BioPharma Conference Transcript
All right. I think we're going to get started. We're running a minute or 2 behind. I'm Ellie Merle, one of the biotech analysts here at UBS. Very happy to have Mirum Pharma here with us at the UBS Biopharma Conference in Miami.
Joining us from Mirum is Eric Bjerkholt, Chief Financial Officer; and Andrew McKibben, VP, Investor Relations and Finance. Guys, thanks so much for joining us. Maybe just to kick it off, you guys have a pretty wide portfolio in most commercial and clinical programs. Can you give us an overview of your pipeline and what you see as the key milestones over the next year?
Absolutely. And Ellie, thanks for having us. It's really fun to be here. And before I start answering the questions, let me say, both Andrew and I will be making forward-looking statements. So please refer to our SEC filings.
So we are building a leading company in rare diseases. Currently, we have 3 approved products for liver
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)